Aminoglycosides are the most preferred choice of therapy against serious infections in humans. Therefore, its use in animal husbandry has been strictly regulated in the EU, UK, and USA to avoid the hazards of aminoglycoside resistance in gut microflora. Nevertheless, aminoglycosides are recommended for prophylaxis and therapeutics in food animals and agriculture owing to its bactericidal nature. In the recent past, the global surge in aminoglycoside-resistant lactic acid bacteria (LAB) from food sources has been noticed that might question its continued use in animal husbandry. Upon antibiotic administration, a selective pressure is created in the gut environment; in such instances, LAB could act as reservoirs of antibiotic resistance which may facilitate their transfer to pathogenic organisms contradicting its probiotic and industrial significance. This may be a risk to human health as the presence of one aminoglycoside resistance gene renders the bacteria tolerant to almost all antibiotics of the same class, thereby challenging its therapeutic efficacy. Low doses of aminoglycosides are recommended in farm animals due to its toxic nature and insolubility in blood. However, recent investigations indicate that use of aminoglycosides in sub-lethal concentrations can trigger the selection and conjugal transfer of aminoglycoside resistance in probiotic LAB. Resistance to erythromycin, tetracyclines, and fluoroquinolones in LAB were reported earlier to which immediate regulatory measures were adopted by some countries. Paradoxically, lack of regulations on antibiotic use in farms in most developing countries makes them a potential source of antibiotic resistance and its uncontrolled spread around the globe. The prevalence of aminoglycoside resistance was observed in enterococci from food origin earlier; however, its emergence in lactobacilli and pediococci suggests its spread in probiotic cultures which prompts immediate precautionary methods. This review highlights the emergence and hazards of aminoglycoside-resistant LAB which is in prime commercial demand both for preparing fermented food and also pharma-based therapeutics. It further focuses on the mode of aminoglycoside resistance and its occurrence in food-grade LAB, thus relating to its role in worldwide transfer via the food chain in spite of its limited use as compared to other antibiotics.
Background & objectives:
Bacterial biofilms a multi-layered defence, comprise extracellular DNA (eDNA) and proteins, protect bacteria from harmful environment and nutrient limitation and utilize the mutual benefits within a community. Bacterial biofilms also defend bacteria from harsh environments such as antibiotic treatment. This leads to poor antibiotic penetration, slow growth, adaptive stress responses, and formation of persister cells. This study was done to determine the relation of antibiotic resistance deciphered by the biofilms in
Lactobacillus plantarum
, a lactic acid bacteria (LAB) with probiotic significance.
Methods:
The gentamicin-resistant
L. plantarum
isolates were allowed to form biofilms and subjected to DNase I and proteinase K treatment. The optical density (OD) values were recorded for the biofilm assay and the cell count for the number of viable cells was taken for the control and the test samples. Percentage reduction was calculated based on the difference between the initial and final OD for both the parameters.
Results:
The biofilm assay revealed that the native
L. plantarum
isolates which were phenotypically susceptible, possessed the ability to form biofilms. The OD values were significantly decreased in comparison to the biofilm-forming control culture when these were treated with DNase I and proteinase K.
Interpretation & conclusions:
The study revealed that the biofilms formed by
L. plantarum
comprised of eDNA and proteins which was evidenced by the reduction in OD values and percentage in comparison to the control upon DNase I and proteinase K treatment. This indicates that the eDNA and biofilm matrix proteins are vital constituents of biofilms and may carry significant risk when coupled with antibiotic resistance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.